Renovaro Biosciences Inc. (RENB)
NASDAQ: RENB · IEX Real-Time Price · USD
1.530
-0.170 (-10.00%)
At close: Apr 26, 2024, 4:00 PM
1.480
-0.050 (-3.27%)
After-hours: Apr 26, 2024, 7:53 PM EDT
Renovaro Biosciences Market Cap
Renovaro Biosciences has a market cap or net worth of $219.81 million as of April 26, 2024. Its market cap has increased by 231.54% in one year.
Market Cap
219.81M
Enterprise Value
225.89M
1-Year Change
231.54%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since December 11, 2018, Renovaro Biosciences's market cap has decreased from $252.00M to $219.81M, a decrease of -12.77%. That is a compound annual growth rate of -2.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 26, 2024 | 219.80M | -9.99% |
| Apr 25, 2024 | 244.20M | -13.71% |
| Apr 24, 2024 | 283.00M | -2.48% |
| Apr 23, 2024 | 290.20M | -6.05% |
| Apr 22, 2024 | 308.90M | -0.93% |
| Apr 19, 2024 | 311.80M | -5.63% |
| Apr 18, 2024 | 330.40M | 3.61% |
| Apr 17, 2024 | 318.90M | -8.28% |
| Apr 16, 2024 | 347.70M | -1.22% |
| Apr 15, 2024 | 352.00M | 3.80% |
| Apr 12, 2024 | 339.10M | -3.66% |
| Apr 11, 2024 | 352.00M | -1.21% |
| Apr 10, 2024 | 356.30M | -11.10% |
| Apr 9, 2024 | 400.80M | -2.12% |
| Apr 8, 2024 | 409.50M | 3.28% |
| Apr 5, 2024 | 396.50M | -1.07% |
| Apr 4, 2024 | 400.80M | 0.70% |
| Apr 3, 2024 | 398.00M | -1.75% |
| Apr 2, 2024 | 405.10M | -6.01% |
| Apr 1, 2024 | 431.00M | 13.21% |
| Mar 28, 2024 | 380.70M | -5.01% |
| Mar 27, 2024 | 400.80M | -4.46% |
| Mar 26, 2024 | 419.50M | 0.33% |
| Mar 25, 2024 | 418.10M | -9.89% |
| Mar 22, 2024 | 464.00M | 9.85% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coherus BioSciences | 231.54M |
| 23andMe Holding Co. | 224.12M |
| Senseonics Holdings | 220.60M |
| uniQure | 219.88M |
| AVITA Medical | 219.81M |
| Ovid Therapeutics | 219.20M |
| 2seventy bio | 218.33M |
| Accuray | 217.18M |